{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:00:57Z","timestamp":1792206057280,"version":"4.4.0"},"reference-count":163,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Ovarian cancer (OC), the seventh most common cancer in women and the most lethal gynecological malignancy, is a significant global health challenge, with &gt;324,000 new cases and &gt;200,000 deaths being reported annually. OC is characterized by late-stage diagnosis, a poor prognosis, and 5-year survival rates ranging from 93% (early stage) to 20% (advanced stage). Despite advances in genomics and proteomics, effective early-stage diagnostic tools and population-wide screening strategies remain elusive, contributing to high mortality rates. The complex pathogenesis of OC involves diverse histological subtypes and genetic predispositions, including BRCA1\/2 mutations; notably, a considerable proportion of OC cases have a hereditary component. Current diagnostic modalities, including imaging techniques (transvaginal ultrasound, computed\/positron emission tomography, and magnetic resonance imaging) and biomarkers (CA-125 and human epididymis protein 4), with varying degrees of sensitivity and specificity, have limited efficacy in detecting early-stage OC. Emerging technologies, such as liquid biopsy, multiomics, and artificial intelligence (AI)-assisted diagnostics, may enhance early detection. Liquid biopsies using circulating tumor DNA and microRNAs are popular minimally invasive diagnostic tools. Integrated multiomics has advanced biomarker discovery. AI algorithms have improved imaging interpretation and risk prediction. Novel screening methods including organoids and multiplex panels are being explored to overcome current diagnostic limitations. This review highlights the critical need for continued research and innovation to enhance early diagnosis, reduce mortality, and improve patient outcomes in OC and posits personalized medicine, integrated emerging technologies, and targeted global initiatives and collaborative efforts, which address care access disparities and promote cost-effective, scalable screening strategies, as potential tools to combat OC.<\/jats:p>","DOI":"10.3390\/diagnostics15040406","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:02:42Z","timestamp":1738918962000},"page":"406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions"],"prefix":"10.3390","volume":"15","author":[{"given":"Mun-Kun","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-068X","authenticated-orcid":false,"given":"Dah-Ching","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"ref_1","unstructured":"World Cancer Research Fund (2025, January 13). Ovarian Cancer Statistics. Available online: https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/ovarian-cancer-statistics\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of Ovarian Cancer: A Review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cco-20-34","article-title":"Epidemiology of Ovarian Cancer","volume":"9","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Moffitt, L., Karimnia, N., Stephens, A., and Bilandzic, M. (2019). Therapeutic Targeting of Collective Invasion in Ovarian Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061466"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2020.02.017","article-title":"Fallopian Tube Initiation of High Grade Serous Ovarian Cancer and Ovarian Metastasis: Mechanisms and Therapeutic Implications","volume":"476","author":"Bergsten","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1568026620999201111155426","article-title":"An Overview of Ovarian Cancer: Molecular Processes Involved and Development of Target-Based Chemotherapeutics","volume":"21","author":"Shaik","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/mc.23586","article-title":"Insulin-like Growth Factor (IGF) and Hepatocyte Growth Factor (HGF) in Follicular Fluid Cooperatively Promote the Oncogenesis of High-Grade Serous Carcinoma from Fallopian Tube Epithelial Cells: Dissection of the Molecular Effects","volume":"62","author":"Chu","year":"2023","journal-title":"Mol. Carcinog."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian Cancer Statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Brain, K.E., Smits, S., Simon, A.E., Forbes, L.J., Roberts, C., Robb\u00e9, I.J., Steward, J., White, C., Neal, R.D., and Hanson, J. (2014). Ovarian Cancer Symptom Awareness and Anticipated Delayed Presentation in a Population Sample. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-171"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"b2998","DOI":"10.1136\/bmj.b2998","article-title":"Risk of Ovarian Cancer in Women with Symptoms in Primary Care: Population Based Case-Control Study","volume":"339","author":"Hamilton","year":"2009","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","article-title":"Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics","volume":"291","author":"Goff","year":"2004","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jnci\/djp500","article-title":"Predictive Value of Symptoms for Early Detection of Ovarian Cancer","volume":"102","author":"Rossing","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hoc.2018.07.003","article-title":"Early Detection of Ovarian Cancer","volume":"32","author":"Elias","year":"2018","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/his.13248","article-title":"High-Grade Serous Carcinoma of Tubo-Ovarian Origin: Recent Developments","volume":"71","author":"Singh","year":"2017","journal-title":"Histopathology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Otsuka, I., and Matsuura, T. (2020). Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding. Diagnostics, 10.","DOI":"10.3390\/diagnostics10020120"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tcmj.2013.04.002","article-title":"The Fallopian Tube Is the Culprit and an Accomplice in Type II Ovarian Cancer: A Review","volume":"25","author":"Hong","year":"2013","journal-title":"Tzu Chi Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kim, J., Park, E.Y., Kim, O., Schilder, J.M., Coffey, D.M., Cho, C.-H., and Bast, R.C. (2018). Cell Origins of High-Grade Serous Ovarian Cancer. Cancers, 10.","DOI":"10.3390\/cancers10110433"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Pelvic High-Grade Serous Carcinoma\u2014Evidence Supporting the Clonal Relationship of the Two Lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A Candidate Precursor to Pelvic Serous Cancer (p53 Signature) and Its Prevalence in Ovaries and Fallopian Tubes from Women with BRCA Mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Babaier, A., Mal, H., Alselwi, W., and Ghatage, P. (2022). Low-Grade Serous Carcinoma of the Ovary: The Current Status. Diagnostics, 12.","DOI":"10.3390\/diagnostics12020458"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2016.08.320","article-title":"Low-Grade Serous Ovarian Cancer: A Review","volume":"143","author":"Kaldawy","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_22","first-page":"650","article-title":"Low-Grade Serous Carcinoma of the Ovary","volume":"30","author":"Grisham","year":"2016","journal-title":"Oncology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"i45","DOI":"10.1093\/annonc\/mdw085","article-title":"Low-Grade Serous Carcinoma of the Ovary or Peritoneum","volume":"27","author":"Gershenson","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13048-021-00804-1","article-title":"Ovarian Endometrioid Carcinoma and Clear Cell Carcinoma: A 21-Year Retrospective Study","volume":"14","author":"Zhou","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2019.07.012","article-title":"Molecular Profiling and Molecular Classification of Endometrioid Ovarian Carcinomas","volume":"154","author":"Cybulska","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0090-8258(22)01395-6","article-title":"Patterns of Spread and Genetic Mutations of Primary Endometrioid Carcinomas of the Ovary (168)","volume":"166","author":"Mazina","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, S., Li, Y., Qian, L., Deng, S., Liu, L., Xiao, W., and Zhou, Y. (2021). A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.668151"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"i50","DOI":"10.1093\/annonc\/mdw086","article-title":"Clear-Cell Carcinoma of the Ovary","volume":"27","author":"Fujiwara","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.22730\/jmls.2014.10.3.236","article-title":"A Case of Clear Cell Carcinoma of the Ovary","volume":"10","author":"Park","year":"2014","journal-title":"J. Med. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2021.06.033","article-title":"Clear Cell Carcinoma of the Ovary: Epidemiology, Pathological and Biological Features, Treatment Options and Clinical Outcomes","volume":"162","author":"Gadducci","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IGC.0000000000000289","article-title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary","volume":"24","author":"Okamoto","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Babaier, A., and Ghatage, P. (2020). Mucinous Cancer of the Ovary: Overview and Current Status. Diagnostics, 10.","DOI":"10.3390\/diagnostics10010052"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2018.01.035","article-title":"Early Stage Mucinous Ovarian Cancer: A Review","volume":"149","author":"Crane","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, Y., Peng, L., Ye, W., and Lu, Y. (2024). Multimodal Diagnostic Strategies and Precision Medicine in Mucinous Ovarian Carcinoma: A Comprehensive Approach. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1391910"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ricci, F., Affatato, R., Carrassa, L., and Damia, G. (2018). Recent Insights into Mucinous Ovarian Carcinoma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061569"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5152\/dir.2015.34414","article-title":"Sex Cord-Stromal Tumors of the Ovary: A Comprehensive Review and Update for Radiologists","volume":"21","author":"Horta","year":"2015","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ijgc-2020-002018","article-title":"Ovarian Sex Cord-Stromal Tumors: An Update on Clinical Features, Molecular Changes, and Management","volume":"31","author":"McNeish","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/IGC.0000000000000223","article-title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Sex Cord Stromal Tumors","volume":"24","author":"Brown","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2214\/ajr.185.1.01850207","article-title":"CT and MRI Findings of Sex Cord-Stromal Tumor of the Ovary","volume":"185","author":"Jung","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.mpdhp.2020.03.006","article-title":"Pathology of Malignant Ovarian Germ Cell Tumours","volume":"26","author":"Kaur","year":"2020","journal-title":"Diagn. Histopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1148\/rg.343130067","article-title":"Ovarian Malignant Germ Cell Tumors: Cellular Classification and Clinical and Imaging Features","volume":"34","author":"Shaaban","year":"2014","journal-title":"Radiographics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2022.07.004","article-title":"Germ Cell Tumors of the Ovary: A Review","volume":"40","author":"Ramalingam","year":"2023","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5603\/OCP.2022.0013","article-title":"What Is New about Germ Cell Ovarian Tumors?","volume":"18","author":"Pilarska","year":"2022","journal-title":"Oncol. Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/ijgc-2020-001556","article-title":"Ovarian Cancer Predisposition beyond BRCA1 and BRCA2 Genes","volume":"30","author":"Pietragalla","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.4103\/ijc.IJC_1394_20","article-title":"BRCA Mutations: Implications of Genetic Testing in Ovarian Cancer","volume":"59","author":"Talwar","year":"2022","journal-title":"Indian J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Angeli, D., Salvi, S., and Tedaldi, G. (2020). Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031128"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.48095\/cccg2022211","article-title":"Ovarian Tumors and Genetic Predisposition","volume":"87","year":"2022","journal-title":"Ceska Gynekol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Whelan, E., Kalliala, I., Semertzidou, A., Raglan, O., Bowden, S., Kechagias, K., Markozannes, G., Cividini, S., McNeish, I., and Marchesi, J. (2022). Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature. Cancers, 14.","DOI":"10.3390\/cancers14112708"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Guo, J.-Z., Xiao, Q., Gao, S., Li, X.-Q., Wu, Q.-J., and Gong, T.-T. (2021). Review of Mendelian Randomization Studies on Ovarian Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.681396"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hanchette, C., Zhang, C.H., and Schwartz, G.G. (2018). Ovarian Cancer Incidence in the U.s. and Toxic Emissions from Pulp and Paper Plants: A Geospatial Analysis. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15081619"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian Cancer: Epidemiology and Risk Factors","volume":"26","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/GRF.0000000000000318","article-title":"Ovarian Cancer Prevention in High-Risk Women","volume":"60","author":"Temkin","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","article-title":"Ovarian Cancer Prevention and Screening","volume":"131","author":"Menon","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e2018.00004","DOI":"10.4293\/JSLS.2018.00004","article-title":"Trends of Opportunistic Salpingectomy","volume":"22","author":"Ding","year":"2018","journal-title":"JSLS"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Liberto, J.M., Chen, S.-Y., Shih, I.-M., Wang, T.-H., Wang, T.-L., and Pisanic, T.R. (2022). Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. Cancers, 14.","DOI":"10.3390\/cancers14122885"},{"key":"ref_56","unstructured":"Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium Members of the EWG SC, in alphabetical order:, Doherty, J.A., Jensen, A., Kelemen, L.E., Pearce, C.L., Poole, E., Schildkraut, J.M., Terry, K.L., Tworoger, S.S., and Webb, P.M. (2017). Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. J. Natl. Cancer Inst., 109, djx144."},{"key":"ref_57","first-page":"e17646","article-title":"Sensitivity and Specificity of Ultrasonography Using Ovarian-Adnexal Reporting and Data System Classification versus Pathology Findings for Ovarian Cancer","volume":"13","year":"2021","journal-title":"Cureus"},{"key":"ref_58","first-page":"347","article-title":"Screening for the Early Detection of Ovarian Cancer","volume":"5","author":"Robertson","year":"2009","journal-title":"Women\u2019s Health"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/AOG.0b013e31823b49b3","article-title":"Can Ovarian Cancer Screening Save Lives? The Question Remains Unanswered","volume":"118","author":"Jacobs","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.ultrasmedbio.2016.05.014","article-title":"Prospective Evaluation of Ultrasound Accuracy in the Detection of Pelvic Carcinomatosis in Patients with Ovarian Cancer","volume":"42","author":"Weinberger","year":"2016","journal-title":"Ultrasound Med. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Suppiah, S. (2018). The Past, Present and Future of Diagnostic Imaging in Ovarian Cancer. Ovarian Cancer\u2014From Pathogenesis to Treatment, InTech.","DOI":"10.5772\/intechopen.74449"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1007\/s00330-020-06937-z","article-title":"Early Detection of Ovarian Cancer","volume":"30","author":"Forstner","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/a-1079-5158","article-title":"CT Scan in the Prediction of Lymph Node Involvement in Ovarian Cancer\u2014A Retrospective Analysis of a Tertiary Gyneco-Oncological Unit","volume":"80","author":"Widschwendter","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.acra.2019.09.019","article-title":"The Value of Contrast-Enhanced CT in the Detection of Residual Disease after Neo-Adjuvant Chemotherapy in Ovarian Cancer","volume":"27","author":"An","year":"2020","journal-title":"Acad. Radiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.acra.2019.04.005","article-title":"The Accuracy of Multi-Detector Computed Tomography and Laparoscopy in the Prediction of Peritoneal Carcinomatosis Index Score in Primary Ovarian Cancer","volume":"26","author":"Ahmed","year":"2019","journal-title":"Acad. Radiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ygyno.2019.08.025","article-title":"Diagnostic Flow-Chart to Identify Bowel Involvement in Patients with Stage IIIC-IV Ovarian Cancer: Can Laparoscopy Improve the Accuracy of CT Scan?","volume":"155","author":"Tozzi","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gagliardi, T., Adejolu, M., and deSouza, N.M. (2022). Diffusion-Weighted Magnetic Resonance Imaging in Ovarian Cancer: Exploiting Strengths and Understanding Limitations. J. Clin. Med., 11.","DOI":"10.3390\/jcm11061524"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Bourgioti, C., Konidari, M., and Moulopoulos, L.A. (2023). Manifestations of Ovarian Cancer in Relation to Other Pelvic Diseases by MRI. Cancers, 15.","DOI":"10.3390\/cancers15072106"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Saida, T., Mori, K., Hoshiai, S., Sakai, M., Urushibara, A., Ishiguro, T., Minami, M., Satoh, T., and Nakajima, T. (2022). Diagnosing Ovarian Cancer on MRI: A Preliminary Study Comparing Deep Learning and Radiologist Assessments. Cancers, 14.","DOI":"10.3390\/cancers14040987"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e223281","DOI":"10.1148\/radiol.223281","article-title":"Adnexal Lesion Imaging: Past, Present, and Future","volume":"307","author":"Sadowski","year":"2023","journal-title":"Radiology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43055-020-0141-5","article-title":"MR Diffusion versus MR Perfusion in Patients with Ovarian Tumors; How Far Could We Get?","volume":"51","author":"Eissawy","year":"2020","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_72","first-page":"e20650","article-title":"Accuracy of MRI Pelvis in the Diagnosis of Ovarian Endometrioma: Using Histopathology as Gold Standard","volume":"13","author":"Siddiqui","year":"2021","journal-title":"Cureus"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/radiology.211.2.r99ma24519","article-title":"Treated Ovarian Cancer: Comparison of MR Imaging with Serum CA-125 Level and Physical Examination--a Longitudinal Study","volume":"211","author":"Low","year":"1999","journal-title":"Radiology"},{"key":"ref_74","first-page":"1727","article-title":"Risk of Malignancy Index in Preoperative Evaluation of Pelvic Masses","volume":"12","author":"Ashrafgangooei","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cpet.2023.12.007","article-title":"PET\/computed Tomography Transformation of Oncology: Ovarian Cancers","volume":"19","author":"Lee","year":"2024","journal-title":"PET Clin."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Rusu, G., Achima\u0219-Cadariu, P., Piciu, A., C\u0103inap, S.S., C\u0103inap, C., and Piciu, D. (2021). A Comparative Study between 18F-FDG PET\/CT and Conventional Imaging in the Evaluation of Progressive Disease and Recurrence in Ovarian Carcinoma. Healthcare, 9.","DOI":"10.3390\/healthcare9060666"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10147-005-0489-6","article-title":"Positron Emission Tomography with 18F-Fluoro-2-Deoxyglucose for the Detection of Recurrent Ovarian Cancer","volume":"10","author":"Takekuma","year":"2005","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Tardieu, A., Ouldamer, L., Margueritte, F., Rossard, L., Lacorre, A., Bourdel, N., Lades, G., Sall\u00e9e, C., Monteil, J., and Gauthier, T. (2021). Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. A FRANCOGYN Group Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040602"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101867","DOI":"10.1016\/j.jogoh.2020.101867","article-title":"Accuracy of Peritoneal Carcinomatosis Extent Diagnosis by Initial FDG PET CT in Epithelial Ovarian Cancer: A Multicentre Study of the FRANCOGYN Research Group","volume":"49","author":"Rossard","year":"2020","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_80","first-page":"1614","article-title":"Advances in Biomarker Discovery and Radiological Techniques for Early Detection of Ovarian Cancer","volume":"6","author":"Alkhalaf","year":"2022","journal-title":"Int. J. Health Sci. (IJHS)"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F.O., Narod, S.A., and Akbari, M.R. (2020). CA125 and Ovarian Cancer: A Comprehensive Review. Cancers, 12.","DOI":"10.3390\/cancers12123730"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/AOG.0000000000005496","article-title":"Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review","volume":"143","author":"Greenwood","year":"2024","journal-title":"Obstet. Gynecol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"17588359241233225","DOI":"10.1177\/17588359241233225","article-title":"Diagnostic Biomarkers in Ovarian Cancer: Advances beyond CA125 and HE4","volume":"16","author":"Ghose","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0090-8258(03)00414-1","article-title":"Preoperative Differentiation of Malignant from Benign Ovarian Tumors: The Efficacy of Morphology Indexing and Doppler Flow Sonography","volume":"91","author":"Ueland","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_86","first-page":"594","article-title":"Risk of Malignancy in Unilocular Ovarian Cystic Tumors Less than 10 Centimeters in Diameter","volume":"102","author":"Modesitt","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-15-2750","article-title":"Early Detection of Ovarian Cancer Using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk\u2014Combined Results from Two Screening Trials","volume":"23","author":"Skates","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"196","DOI":"10.32598\/jams.24.2.6002.1","article-title":"Evaluating Specivity, Sensitivity, Positive and Negative Predictive Values of CA125 for Diagnosing Ovarian Cancer","volume":"24","author":"Fini","year":"2021","journal-title":"J. Arak Univ. Med. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/1933719113505846","article-title":"In the Spotlight","volume":"20","author":"Maduro","year":"2013","journal-title":"Reprod. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cncr.23577","article-title":"Combining a Symptoms Index with CA 125 to Improve Detection of Ovarian Cancer","volume":"113","author":"Andersen","year":"2008","journal-title":"Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zhang, R., Siu, M.K.Y., Ngan, H.Y.S., and Chan, K.K.L. (2022). Molecular Biomarkers for the Early Detection of Ovarian Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231912041"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14737140.2017.1360138","article-title":"The Role of Novel Biomarker HE4 in the Diagnosis, Prognosis and Follow-up of Ovarian Cancer: A Systematic Review","volume":"17","author":"Scaletta","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2017.08.020","article-title":"Combining a Symptom Index, CA125 and HE4 (triple Screen) to Detect Ovarian Cancer in Women with a Pelvic Mass","volume":"147","author":"Goff","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Rastogi, M., Gupta, S., and Sachan, M. (2016). Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects. Braz. Arch. Biol. Technol., 59.","DOI":"10.1590\/1678-4324-2016160070"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/1940-6207.CAPR-14-0248","article-title":"A Multiplexable, Microfluidic Platform for the Rapid Quantitation of a Biomarker Panel for Early Ovarian Cancer Detection at the Point-of-Care","volume":"8","author":"Shadfan","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kim, Y.-W., Bae, S.M., Lim, H., Kim, Y.J., and Ahn, W.S. (2012). Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044960"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2013.04.048","article-title":"A Multiplex Methylation-Specific PCR Assay for the Detection of Early-Stage Ovarian Cancer Using Cell-Free Serum DNA","volume":"130","author":"Zhang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12014-017-9169-6","article-title":"A Multiplex Platform for the Identification of Ovarian Cancer Biomarkers","volume":"14","author":"Boylan","year":"2017","journal-title":"Clin. Proteomics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.10.014","article-title":"Liquid Biopsy in Ovarian Cancer Using Circulating Tumor DNA and Cells: Ready for Prime Time?","volume":"468","author":"Asante","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1515\/cclm-2017-0019","article-title":"Liquid Biopsy in Ovarian Cancer: Recent Advances on Circulating Tumor Cells and Circulating Tumor DNA","volume":"56","author":"Giannopoulou","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2020.06.047","article-title":"Liquid Biopsy in Ovarian Cancer","volume":"510","author":"Bhardwaj","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.acc.2020.01.001","article-title":"Liquid Biopsy in Ovarian Cancer","volume":"97","author":"Giannopoulou","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13048-019-0494-4","article-title":"Next-Generation Sequencing-Based Genomic Profiling Analysis Reveals Novel Mutations for Clinical Diagnosis in Chinese Primary Epithelial Ovarian Cancer Patients","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/1078-0432.CCR-21-1643","article-title":"The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma","volume":"28","author":"Cheng","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3349\/ymj.2019.60.10.914","article-title":"Integrating a next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2018.10.002","article-title":"RNA Sequencing (RNA-Seq) and Its Application in Ovarian Cancer","volume":"152","author":"Wang","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13048-022-01068-z","article-title":"Can Circulating Cell Free DNA Be a Promising Marker in Ovarian Cancer?\u2014A Genome-Scale Profiling Study in a Single Institution","volume":"16","author":"Zhou","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Guo, X.M., Miller, H., Matsuo, K., Roman, L.D., and Salhia, B. (2021). Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature. Cancers, 13.","DOI":"10.3390\/cancers13040838"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Bi, M., Guo, H., and Li, M. (2022). Multi-Omics Approaches for Biomarker Discovery in Early Ovarian Cancer Diagnosis. EBioMedicine, 79.","DOI":"10.1016\/j.ebiom.2022.104001"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13048-018-0460-6","article-title":"Mass Spectrometry-Based Proteomics Techniques and Their Application in Ovarian Cancer Research","volume":"11","author":"Swiatly","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Ryu, J., and Thomas, S.N. (2021). Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer. Molecules, 26.","DOI":"10.3390\/molecules26092674"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ghose, A., Gullapalli, S.V.N., Chohan, N., Bolina, A., Moschetta, M., Rassy, E., and Boussios, S. (2022). Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. Proteomes, 10.","DOI":"10.3390\/proteomes10020016"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force, Grossman, D.C., Curry, S.J., Owens, D.K., Barry, M.J., Davidson, K.W., Doubeni, C.A., Epling, J.W., Kemper, A.R., and Krist, A.H. (2018). Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 319, 588\u2013594.","DOI":"10.1001\/jama.2017.21926"},{"key":"ref_114","first-page":"3","article-title":"Screening for Ovarian Cancer: An Update","volume":"10","author":"Patni","year":"2019","journal-title":"J. Midlife. Health"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","article-title":"CA125 and Transvaginal Ultrasound Monitoring in High-Risk Women Cannot Prevent the Diagnosis of Advanced Ovarian Cancer","volume":"100","author":"Olivier","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/beog.2002.9305","article-title":"Prophylactic Oophorectomy","volume":"16","author":"Coukos","year":"2002","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral Salpingectomy Can Reduce the Risk of Ovarian Cancer in the General Population: A Meta-Analysis","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.24920\/003963","article-title":"Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers","volume":"36","author":"Chen","year":"2021","journal-title":"Chin. Med. Sci. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"101662","DOI":"10.1016\/j.eclinm.2022.101662","article-title":"Artificial Intelligence Performance in Image-Based Ovarian Cancer Identification: A Systematic Review and Meta-Analysis","volume":"53","author":"Xu","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3892\/or.2024.8705","article-title":"Advances in Artificial Intelligence for the Diagnosis and Treatment of Ovarian Cancer (Review)","volume":"51","author":"Wang","year":"2024","journal-title":"Oncol. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3233\/CBM-210301","article-title":"Applications of Artificial Intelligence (AI) in Ovarian Cancer, Pancreatic Cancer, and Image Biomarker Discovery","volume":"33","author":"Mikdadi","year":"2022","journal-title":"Cancer Biomark."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.21873\/anticanres.14482","article-title":"Artificial Intelligence in Ovarian Cancer Diagnosis","volume":"40","author":"Akazawa","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e2203","DOI":"10.1002\/hsr2.2203","article-title":"Prediction of Ovarian Cancer Using Artificial Intelligence Tools","volume":"7","author":"Ayyoubzadeh","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Zhou, J., Cao, W., Wang, L., Pan, Z., and Fu, Y. (2022). Application of Artificial Intelligence in the Diagnosis and Prognostic Prediction of Ovarian Cancer. Comput. Biol. Med., 146.","DOI":"10.1016\/j.compbiomed.2022.105608"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Nopour, R. (2024). Screening Ovarian Cancer by Using Risk Factors: Machine Learning Assists. Biomed. Eng. Online, 23.","DOI":"10.1186\/s12938-024-01219-x"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/tcmj.tcmj_63_21","article-title":"The Organoid: A Research Model for Ovarian Cancer","volume":"34","author":"Chang","year":"2022","journal-title":"Tzu Chi Med. J."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Chang, Y.-H., Chu, T.-Y., and Ding, D.-C. (2020). Human Fallopian Tube Epithelial Cells Exhibit Stemness Features, Self-Renewal Capacity, and Wnt-Related Organoid Formation. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-019-0602-1"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13048-019-0577-2","article-title":"Organoids of Epithelial Ovarian Cancer as an Emerging Preclinical in Vitro Tool: A Review","volume":"12","author":"Dumont","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00432-024-05654-0","article-title":"Organoids in Ovarian Cancer: A Platform for Disease Modeling, Precision Medicine, and Drug Assessment","volume":"150","author":"Hu","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Psilopatis, I., Sykaras, A.G., Mandrakis, G., Vrettou, K., and Theocharis, S. (2022). Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010001"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"9636897241281869","DOI":"10.1177\/09636897241281869","article-title":"Ovarian Cancer Patient-Derived Organoids Used as a Model for Replicating Genetic Characteristics and Testing Drug Responsiveness: A Preliminary Study","volume":"33","author":"Chang","year":"2024","journal-title":"Cell Transplant."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41746-020-00351-x","article-title":"Harnessing Consumer Smartphone and Wearable Sensors for Clinical Cancer Research","volume":"3","author":"Low","year":"2020","journal-title":"NPJ Digit. Med."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., and Velikova, G. (2022). Electronic Patient-Reported Monitoring of Symptoms during Follow-up of Ovarian Cancer Patients: A Feasibility Study. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09817-5"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"103314","DOI":"10.1016\/j.drudis.2022.06.014","article-title":"Wearable Smart Devices in Cancer Diagnosis and Remote Clinical Trial Monitoring: Transforming the Healthcare Applications","volume":"27","author":"Beg","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"013002","DOI":"10.1088\/2057-1739\/aa5cf1","article-title":"Review Article: Novel Technologies in the Treatment and Monitoring of Advanced and Relapsed Epithelial Ovarian Cancer","volume":"3","author":"Cunnea","year":"2017","journal-title":"Converg. Sci. Phys. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-019-0773-3","article-title":"Ovarian Cancer Detection by DNA Methylation in Cervical Scrapings","volume":"11","author":"Wu","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3802\/jgo.2018.29.e17","article-title":"The Feasibility of Detecting Endometrial and Ovarian Cancer Using DNA Methylation Biomarkers in Cervical Scrapings","volume":"29","author":"Chang","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1541-7786.289.2.5","article-title":"Detecting Cervical Cancer by Quantitative Promoter Hypermethylation Assay on Cervical Scrapings: A Feasibility Study","volume":"2","author":"Wisman","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41467-021-26615-y","article-title":"The DNA Methylome of Cervical Cells Can Predict the Presence of Ovarian Cancer","volume":"13","author":"Barrett","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Blagden, S.P. (2015). Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00149"},{"key":"ref_141","first-page":"41","article-title":"Ovarian Cancer: A Heterogeneous Disease","volume":"85","author":"Leary","year":"2017","journal-title":"Pathobiology"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Roberts, C.M., Cardenas, C., and Tedja, R. (2019). The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis. Cancers, 11.","DOI":"10.3390\/cancers11081083"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Karpinskyj, C., Burnell, M., Gonzalez-Izquierdo, A., Ryan, A., Kalsi, J., Jacobs, I., Parmar, M., Menon, U., and Gentry-Maharaj, A. (2020). Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested within UKCTOCS. Diagnostics, 10.","DOI":"10.3390\/diagnostics10020089"},{"key":"ref_144","first-page":"e40309","article-title":"Barriers of Care to Ovarian Cancer: A Scoping Review","volume":"15","author":"Rizvi","year":"2023","journal-title":"Cureus"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"100458","DOI":"10.1016\/j.jcpo.2023.100458","article-title":"Where Are the Inequalities in Ovarian Cancer Care in a Country with Universal Healthcare? A Systematic Review and Narrative Synthesis","volume":"39","author":"Greenley","year":"2024","journal-title":"J. Cancer Policy"},{"key":"ref_146","first-page":"13","article-title":"A Review of the Effects of Healthcare Disparities on the Experience and Survival of Ovarian Cancer Patients of Different Racial and Ethnic Backgrounds","volume":"5","author":"Kaufman","year":"2019","journal-title":"J. Cancer Metastasis Treat."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"476","DOI":"10.17816\/KMJ2022-476","article-title":"Early Diagnostics and Screening for Ovarian Cancer","volume":"103","author":"Savinova","year":"2022","journal-title":"Kazan. Med. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ygyno.2016.04.541","article-title":"\u201cOvarian Cancers: Evolving Paradigms in Research and Care\u201d: Report from the Institute of Medicine","volume":"141","author":"Alvarez","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"101376","DOI":"10.1016\/j.gore.2024.101376","article-title":"Ovarian Cancer Think Tank: An Overview of the Current Status of Ovarian Cancer Screening and Recommendations for Future Directions","volume":"53","author":"Dexter","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1188\/15.CJON.206-212","article-title":"Awareness of Symptoms and Risk Factors of Ovarian Cancer in a Population of Women and Healthcare Providers","volume":"19","author":"Goldstein","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s13187-017-1245-0","article-title":"Ovarian Cancer Knowledge in Women and Providers Following Education with Inside Knowledge Campaign Materials","volume":"33","author":"Puckett","year":"2018","journal-title":"J. Cancer Educ."},{"key":"ref_152","first-page":"10","article-title":"Awareness of Working Women in Mansoura University about Ovarian Cancer: An Intervention Follow-up Study","volume":"6","author":"Mohamed","year":"2015","journal-title":"J. Nurs. Educ. Pract."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/sj.bjc.6605809","article-title":"UKCTOCS Trialists Awareness of Ovarian Cancer Risk Factors, Beliefs and Attitudes towards Screening: Baseline Survey of 21,715 Women Participating in the UK Collaborative Trial of Ovarian Cancer Screening","volume":"103","author":"Fallowfield","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Ye, M., Lin, Y., Pan, S., Wang, Z.-W., and Zhu, X. (2021). Applications of Multi-Omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.745808"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Hira, M.T., Razzaque, M.A., Angione, C., Scrivens, J., Sawan, S., and Sarker, M. (2021). Integrated Multi-Omics Analysis of Ovarian Cancer Using Variational Autoencoders. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-85285-4"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1875692115666170616093844","article-title":"Multi-Omics and Machine Learning Applications in Precision Medicine","volume":"15","author":"Lin","year":"2018","journal-title":"Curr. Pharmacogenomics Person. Med."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Ahn, H.-S., Yeom, J., Yu, J., Kwon, Y.-I., Kim, J.-H., and Kim, K. (2020). Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer. Cancers, 12.","DOI":"10.3390\/cancers12113447"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"\u017dilovi\u010d, D., \u010ciurlien\u0117, R., Sabaliauskait\u0117, R., and Jarmalait\u0117, S. (2021). Future Screening Prospects for Ovarian Cancer. Cancers, 13.","DOI":"10.3390\/cancers13153840"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11912-019-0816-0","article-title":"Novel Approaches to Ovarian Cancer Screening","volume":"21","author":"Nebgen","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1038\/s41467-018-06434-4","article-title":"Integrated Extracellular microRNA Profiling for Ovarian Cancer Screening","volume":"9","author":"Yokoi","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/EDBK_100008","article-title":"Global Health Initiatives of the International Oncology Community","volume":"37","author":"Gospodarowicz","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2015.03.009","article-title":"Global Health Perspective on Gynecologic Oncology","volume":"137","author":"Rice","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.canep.2009.10.003","article-title":"Breast Cancer as a Global Health Concern","volume":"33","author":"Coughlin","year":"2009","journal-title":"Cancer Epidemiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/4\/406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:53Z","timestamp":1760027333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/4\/406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":163,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["diagnostics15040406"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15040406","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}